Synagis Sales Data
| Rank 30 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: May 2013 (updated quarterly).
The following data shows Synagis U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q1 2013 | 30 ( 16) |
$412,703 | 46.47% | 238 | 44.24% |
| Q4 2012 | 46 ( ) |
$281,760 |  |
165 | |
| Q1 2012 | 36 (15) |
$396,556 | 38.30% | 240 | 38.73% |
| Q4 2011 | 51 () |
$286,731 | |
173 | |
| Q1 2011 | 35 | $403,493 | |
263 | |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
